Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evoskin vs Trixiera for skin protection during breast radiotherapy
NCT02334345Completed
- Sponsor
- CHU de Limoges
- Start
- Jan 2015
- Primary completion
- Nov 2015
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Evoskin in radiation dermatitis, sponsored by CHU de Limoges. Primary endpoint: Average of the radiation dermatitis intensity at 3 months. Started Jan 2015; status: completed.
02
Drugs
Evoskin
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT02334345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334345.